Atibuclimab | Interleukin Related interleukin-related.com

Product Name :
Atibuclimab

Search keywords :
Atibuclimab

drugId :
null

Target Vo:
Monocyte differentiation antigen CD14

Target Vo Short Name :
CD14

Moa_Name:
Monocyte differentiation antigen CD14 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Icos Corporation

Active Company_Name :
Implicit Bioscience Inc

Active Indication_Name:
Cardiomyopathies

In Active Indication_Name:
Respiratory Distress Syndrome, Adult

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NLRP3 Antibody
STAT2 Antibody (YA057)
RPA70 Antibody (YA678): RPA70 Antibody (YA678) is a non-conjugated and Mouse origined monoclonal antibody about 68 kDa, targeting to RPA70 (8C3). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey, Mouse, Rat.

Author: Interleukin Related

Related Posts